Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fazzi

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Minerva Ginecologica|December 1, 1987
[Conservative treatment in tubal pregnancy]F Scarpa, G R Fazzi, R Marotta, et al.
Minerva Ginecologica|May 1, 1985
[Microsurgery and tubal sterility]F Scarpa, G R Fazzi, R Zecca, et al.
Leukemia & Lymphoma|April 11, 2003
Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphomaR Riccioni, S Galimberti, G Cervetti, et al.
European Journal of Clinical Investigation|June 16, 2009
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cellsI Petrini, S Pacini, M Petrini, et al.
Bone Marrow Transplantation|August 24, 1999
Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemiaS Galimberti, F Papineschi, A Carmignani, et al.
Bone Marrow Transplantation|February 3, 2004
A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblingsF Papineschi, E Benedetti, S Galimberti, et al.
Annals of Hematology|January 18, 2002
Unusual morphology in a case of large granular cell leukemiaS Galimberti, R Riccioni, A Azzarà, et al.
European Journal of Clinical Investigation|March 18, 2004
Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with ImatinibG Cervetti, S Galimberti, R Fazzi, et al.
Bone Marrow Transplantation|January 27, 2004
Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donorE Orciuolo, A Azzarà, G Bandini, et al.
Leukemia Research|March 3, 2007
Skin and stomach graft versus host disease after syngeneic BMT in CML: a case reportM Pelosini, S Galimberti, E Benedetti, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Minerva Ginecologica|December 1, 1987
[Conservative treatment in tubal pregnancy]F Scarpa, G R Fazzi, R Marotta, et al.
Minerva Ginecologica|May 1, 1985
[Microsurgery and tubal sterility]F Scarpa, G R Fazzi, R Zecca, et al.
Leukemia & Lymphoma|April 11, 2003
Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphomaR Riccioni, S Galimberti, G Cervetti, et al.
European Journal of Clinical Investigation|June 16, 2009
Mesenchymal cells inhibit expansion but not cytotoxicity exerted by gamma-delta T cellsI Petrini, S Pacini, M Petrini, et al.
Bone Marrow Transplantation|August 24, 1999
Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemiaS Galimberti, F Papineschi, A Carmignani, et al.
Bone Marrow Transplantation|February 3, 2004
A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblingsF Papineschi, E Benedetti, S Galimberti, et al.
Annals of Hematology|January 18, 2002
Unusual morphology in a case of large granular cell leukemiaS Galimberti, R Riccioni, A Azzarà, et al.
European Journal of Clinical Investigation|March 18, 2004
Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with ImatinibG Cervetti, S Galimberti, R Fazzi, et al.
Bone Marrow Transplantation|January 27, 2004
Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donorE Orciuolo, A Azzarà, G Bandini, et al.
Leukemia Research|March 3, 2007
Skin and stomach graft versus host disease after syngeneic BMT in CML: a case reportM Pelosini, S Galimberti, E Benedetti, et al.
Pageof 3